These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32739118)

  • 61. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Glycolipid α-GalCer Derivative, 7DW8-5 as a Novel Mucosal Adjuvant for the Split Inactivated Influenza Vaccine.
    Feng H; Sun R; Song G; Zhu S; Nie Z; Lin L; Yi R; Wu S; Wang G; He Y; Wang S; Wang P; Wu L; Shu J
    Viruses; 2022 May; 14(6):. PubMed ID: 35746644
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine.
    Rioux G; Mathieu C; Russell A; Bolduc M; Laliberté-Gagné ME; Savard P; Leclerc D
    J Nanobiotechnology; 2014 May; 12():19. PubMed ID: 24885884
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine.
    Katz JM; Lu X; Young SA; Galphin JC
    J Infect Dis; 1997 Feb; 175(2):352-63. PubMed ID: 9203656
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice.
    Wu J; Wang F; Fang F; Zhang W; Chang H; Zheng L; Chen Z
    Arch Virol; 2011 Mar; 156(3):387-95. PubMed ID: 21110049
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs.
    Magiri R; Lai K; Chaffey A; Zhou Y; Pyo HM; Gerdts V; Wilson HL; Mutwiri G
    Vaccine; 2018 Mar; 36(12):1606-1613. PubMed ID: 29454517
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intranasal hydroxypropyl-β-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection.
    Kusakabe T; Ozasa K; Kobari S; Momota M; Kishishita N; Kobiyama K; Kuroda E; Ishii KJ
    Vaccine; 2016 Jun; 34(27):3191-3198. PubMed ID: 27160037
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Toward a universal influenza virus vaccine: Some cytokines may fulfill the request.
    Taheri M; Nemattalab M; Mahjoob M; Hasan-Alizadeh E; Zamani N; Nikokar I; Evazalipour M; Soltani Tehrani B; Shenagari M
    Cytokine; 2021 Dec; 148():155703. PubMed ID: 34555604
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo.
    Noh K; Jeong EJ; An T; Shin JS; Kim H; Han SB; Kim M
    J Microbiol; 2022 May; 60(5):550-559. PubMed ID: 35437625
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adjuvanted influenza vaccine administered intradermally elicits robust long-term immune responses that confer protection from lethal challenge.
    Martin Mdel P; Seth S; Koutsonanos DG; Jacob J; Compans RW; Skountzou I
    PLoS One; 2010 May; 5(5):e10897. PubMed ID: 20531947
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge.
    Prabakaran M; Kolpe AB; He F; Kwang J
    Vaccine; 2013 Feb; 31(10):1385-92. PubMed ID: 23328313
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.
    Ko EJ; Lee YT; Kim KH; Jung YJ; Lee Y; Denning TL; Kang SM
    J Virol; 2016 Aug; 90(15):6976-6988. PubMed ID: 27226368
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses.
    Tateishi K; Fujihashi K; Yamamoto N; Hasegawa H; Ainai A; Sato K; Iho S; Yamamoto S; Maeyama JI; Odagiri T; Asanuma H
    Vaccine; 2019 Aug; 37(36):5382-5389. PubMed ID: 31345642
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvant.
    Murugappan S; Frijlink HW; Petrovsky N; Hinrichs WL
    Eur J Pharm Sci; 2015 Jan; 66():118-22. PubMed ID: 25459531
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of an Alternative Modified Live Influenza B Virus Vaccine.
    Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immune Response and Protective Efficacy of Inactivated and Live Influenza Vaccines Against Homologous and Heterosubtypic Challenge.
    Boravleva EY; Lunitsin AV; Kaplun AP; Bykova NV; Krasilnikov IV; Gambaryan AS
    Biochemistry (Mosc); 2020 May; 85(5):553-566. PubMed ID: 32571185
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
    Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
    Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.
    Lee YN; Lee YT; Kim MC; Gewirtz AT; Kang SM
    J Immunol; 2016 Mar; 196(6):2637-45. PubMed ID: 26864033
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
    Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
    Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.